What does PCRAF stand for?

Paul Capital Royalty Acquisition Fund (investing; UK)

This definition appears very rarely and is found in the following Acronym Finder categories:

Business, finance, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Program Certification and Resident Assessment Program for Cultural Resource Assessment Programmatic Comparative Risk Analysis Programme Canadien des Recherches Antarctiques Programme Canadien du Revenu Agricole (Canada) Protection Cathodique et Revêtements Associés Protection of Civil Rights Act, 1955 (India) Provo City Redevelopment Agency pyrroline-5-carboxylate reductase Professional Calf Rearers Association Australia (Bakery Hill, Victoria, Australia)		Phase-Change Random Access Memory (non-volatile computer memory) Packet Computing Resource Board (Motorola, Inc.) Peer Conduct Review Board (various schools) Pennsylvania Compensation Rating Bureau Police Complaint Review Board Posterior Cramer-Rao Bound Program Change Review Board Personal Computer Radar Based Simulator Premium Color Ring Back Tone Pacific Concerns Resource Centre (Nuclear Free and Independent Pacific Movement)

Samples in periodicals archive:

The sale will require SkyePharma to restructure its two loans with Paul Capital Royalty Acquisition Fund LLP.

SkyePharma Cuts Its Losses And Sells Injectable Unit

However, IFRS materially alters the composition of our reported Profit & Loss account, particularly as regards the recognition of milestone payments and the treatment of our transactions with Paul Capital Royalty Acquisition Fund that have been used to fund part of our late-stage clinical development programme.

SkyePharma Restates 2004 Financial Information for IFRS

To aid the reorganisation of the group ML has obtained pounds 5m from the Paul Capital Royalty Acquisition Fund following an investment of pounds 17.

ML Labs pinning future on cancer treatments

Paul Capital Partners, through its Paul Capital Royalty Acquisition Fund, raised US dlrs310 million for the purchase of royalty and revenue interests in a variety of life sciences products and companies.

VENTIV HEALTH, MDS PHARMA SERVICES AND PAUL CAPITAL PARTNERS FORM ...

on the cusp of commercialization, said it completed a financing with Paul Capital Royalty Acquisition Fund for up to $25 million in non-equity capital, all but $5 million contingent on regulatory approval and milestones related to the company's human tissue treatments.

ORTEC SECURES UP TO $25M PRIOR TO LAUNCH OF ORCEL

NASDAQ: ORTC), a tissue engineering company, announced today that, under the terms of a previously announced $15 million non-equity financing, consummated in August 2001, it has received a second $5 million payment from Paul Capital Royalty Acquisition Fund (Paul Royalty).

Ortec Receives Additional $5 Million Non Equity-Capital from Paul ...

5 million received in the second quarter under its agreement with Paul Capital Royalty Acquisition Fund, L.

Gliatech Announces Second Quarter 2001 Results

of New York, signed a letter of intent with the Paul Capital Royalty Acquisition Fund, of New York, for the fund to provide up to $25 million of non-equity capital to Ortec based on achieving specified milestones.

OTHER NEWS TO NOTE